The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled?

@article{Goldberg2007TheNC,
  title={The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled?},
  author={R. Goldberg},
  journal={Current opinion in lipidology},
  year={2007},
  volume={18 4},
  pages={435-42}
}
  • R. Goldberg
  • Published 2007 in Current opinion in lipidology
PURPOSE OF REVIEW Despite extensive documentation of their insulin-sensitizing and antihyperglycemic effects, the importance and place of the thiazolidinediones in diabetes management remain unclear. Three new controlled clinical trials of thiazolidinediones offer new information on the clinical utility of these agents. RECENT FINDINGS During the past year, three new trials of thiazolidinediones were reported. In Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication… CONTINUE READING
9 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…